Robin L. Washington

2019

In 2019, Robin L. Washington earned a total compensation of $6.3M as Former Executive Vice President, Chief Financial Officer at Gilead Sciences, which was about the same as previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,370,630
Option Awards$999,978
Salary$1,064,615
Stock Awards$2,893,782
Other$12,000
Total$6,341,005

Washington received $2.9M in stock awards, accounting for 46% of the total pay in 2019.

Washington also received $1.4M in non-equity incentive plan, $1M in option awards, $1.1M in salary and $12K in other compensation.

Rankings

In 2019, Robin L. Washington's compensation ranked 1,578th out of 13,971 executives tracked by ExecPay. In other words, Washington earned more than 88.7% of executives.

ClassificationRankingPercentile
All
1,578
out of 13,971
89th
Division
Manufacturing
569
out of 5,701
90th
Major group
Chemicals And Allied Products
170
out of 2,200
92nd
Industry group
Drugs
136
out of 1,886
93rd
Industry
Biological Products, Except Diagnostic Substances
30
out of 389
92nd

Pay ratio

Robin L. Washington's Pay$6,341,005
Median Employee's Pay$173,264
Pay Ratio

37

to 1

In 2019, the annual total compensation of Robin L. Washington was $6,341,005.

The annual total compensation of the median employee at Gilead Sciences was $173,264.

The ratio of Robin L. Washington's pay to the pay of median employee was therefore 37 to one.

Source: SEC filing on March 24, 2020.

Washington's colleagues

We found eight more compensation records of executives who worked with Robin L. Washington at Gilead Sciences in 2019.

2019

Daniel O'Day

Gilead Sciences

Chief Executive Officer

2019

Johanna Mercier

Gilead Sciences

Chief Commercial Officer

2019

Gregg Alton

Gilead Sciences

Chief Executive Officer

2019

Laura Hamill

Gilead Sciences

Former Executive Vice President Worldwide Commercial Operations

2019

Andrew Dickinson

Gilead Sciences

Chief Financial Officer

2019

John McHutchison

Gilead Sciences

Chief Scientific Officer

2019

Brett Pletcher

Gilead Sciences

General Counsel

2019

Merdad Parsey

Gilead Sciences

Chief Medical Officer

News

You may also like